Don't Read Too Much Into AbbVie Case, FTC's Feinstein Says
The Federal Trade Commission's first pay-for-delay case after the U.S. Supreme Court's landmark Actavis Inc. ruling may have veered from the antitrust watchdog's typical approach to the suits, but that doesn't...To view the full article, register now.
Already a subscriber? Click here to view full article